RBR-9v9r6vj招募中Unknown
Evaluation of the effectiveness of Cardioprotective Nutrition in patients with Metabolic Syndrome and High Blood Pressure: a randomized clinical trial
niversidade do Estado da Bahia - UNEB0 个研究点开始时间: 2024年4月12日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20Y 至 0（—）
入选标准
- •Adults and elderly people. Both sexes. Minimum age of 20 years. Diagnosis of hypertension (140 and/or 90 mmHg). Patients with metabolic syndrome. based on the IDF diagnosis (International Diabetes Federation, 2006)
排除标准
- •Pregnant women;nursing mothers; patients with severe heart failure;undergoing gastroplasty;with liver and/or kidney failure;previous history of encephalopathy or anasarca;with any and all neurocognitive conditions or with mental disorders (defined by their clinical history) will not be included in the research. or in clinical investigation); transplanted patients;patients with gastroplasty and those who have a life expectancy equal to or less than 6 months (eg those with malignant metastasis); wheelchair users, patients undergoing treatment for all and
- •any type of cancer and those with difficulties to feed orally
研究者
相似试验
招募中
3 期
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
已完成
不适用
Cardiovascular risk reduction study: supported by an integrated dietary approachCardiovascular diseaseISRCTN92382106King's College London (KCL) (UK)196
尚未招募
Unknown
A clinical trial to study the cardioprotective effect of remote ischemic preconditioning in acute coronary syndrome patientsCTRI/2023/10/058663Department of Health Research
进行中（未招募）
1 期
Evaluation of the protective effect on the heart of a betablocker drug, nebivolol, in patients with breast cancer or diffuse B-cell lymphoma for which anthracyclinic chemotherapy has been plannedTo prevent cardiotoxicity of chemotherapeutic agents (anthracyclines)MedDRA version: 20.1Level: PTClassification code 10008444Term: Chemotherapy cardiotoxicity attenuationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2017-004618-24-ITIRCCS ISTITUTO CLINICO HUMANITAS80
已完成
不适用
Comparative analysis of two solutions for miocardial protection in the correction of congenital cardiopathies.Children with acyanogenic congenital heart defects operated for total correctionTraced problems - Myocardial damageSpecific descriptors - Interventricular communication, Atrioventricular communication, Right ventricle with double outlet, Tetralogy of Fallot, Myocardial protection.Q21.0Q21.2Q20.1Q21.3C14.280H02.403.670C14.280.647C14.280.671RBR-9wqbx9Hospital do Coração de Messejana Dr. Carlos Alberto Studart Gomes